S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold

Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Datatec Limited stock logo
DTTLY
Datatec
$3.60
$4.04
$3.22
$4.61
$413.14M0.2561 shsN/A
Allkem Limited stock logo
OROCF
Allkem
$6.80
+1.5%
$6.80
$5.34
$11.66
N/A1.6814,560 shs1,900 shs
Oxford Biomedica plc stock logo
OXBDF
Oxford Biomedica
$2.62
$2.43
$2.09
$6.02
$251.72M1.15184 shsN/A
Pharma Mar, S.A. stock logo
PHMMF
Pharma Mar
$26.85
$33.75
$26.85
$46.26
N/A0.220 shsN/A
SThree plc stock logo
STREF
SThree
$3.44
$3.44
$3.30
$3.44
N/AN/AN/AN/A
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Datatec Limited stock logo
DTTLY
Datatec
0.00%0.00%-7.10%-16.28%-19.19%
Allkem Limited stock logo
OROCF
Allkem
0.00%0.00%0.00%0.00%-16.51%
Oxford Biomedica plc stock logo
OXBDF
Oxford Biomedica
0.00%-0.38%+8.96%+11.51%-52.67%
Pharma Mar, S.A. stock logo
PHMMF
Pharma Mar
0.00%-8.33%-11.61%-37.97%-40.85%
SThree plc stock logo
STREF
SThree
0.00%0.00%0.00%0.00%0.00%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Datatec Limited stock logo
DTTLY
Datatec
N/AN/AN/AN/AN/AN/AN/AN/A
Allkem Limited stock logo
OROCF
Allkem
N/AN/AN/AN/AN/AN/AN/AN/A
Oxford Biomedica plc stock logo
OXBDF
Oxford Biomedica
N/AN/AN/AN/AN/AN/AN/AN/A
Pharma Mar, S.A. stock logo
PHMMF
Pharma Mar
N/AN/AN/AN/AN/AN/AN/AN/A
SThree plc stock logo
STREF
SThree
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Datatec Limited stock logo
DTTLY
Datatec
N/AN/AN/AN/A
Allkem Limited stock logo
OROCF
Allkem
2.00
HoldN/AN/A
Oxford Biomedica plc stock logo
OXBDF
Oxford Biomedica
2.40
HoldN/AN/A
Pharma Mar, S.A. stock logo
PHMMF
Pharma Mar
N/AN/AN/AN/A
SThree plc stock logo
STREF
SThree
N/AN/AN/AN/A

Current Analyst Ratings

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Datatec Limited stock logo
DTTLY
Datatec
$5.14B0.08$0.77 per share4.70$4.73 per share0.76
Allkem Limited stock logo
OROCF
Allkem
$1.21BN/A$1.10 per share6.16$8.96 per shareN/A
Oxford Biomedica plc stock logo
OXBDF
Oxford Biomedica
$173.19M1.45N/AN/A$3.03 per share0.86
Pharma Mar, S.A. stock logo
PHMMF
Pharma Mar
$171.15MN/A$3.23 per share8.30$13.04 per shareN/A
SThree plc stock logo
STREF
SThree
N/AN/AN/AN/AN/AN/A

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Datatec Limited stock logo
DTTLY
Datatec
$80.33MN/A0.006.55N/AN/AN/AN/AN/A
Allkem Limited stock logo
OROCF
Allkem
$441.71MN/A0.0042.50N/AN/AN/AN/AN/A
Oxford Biomedica plc stock logo
OXBDF
Oxford Biomedica
-$48.43MN/A0.00N/AN/AN/AN/AN/AN/A
Pharma Mar, S.A. stock logo
PHMMF
Pharma Mar
$1.23MN/A0.00N/AN/AN/AN/AN/A
SThree plc stock logo
STREF
SThree
N/AN/A0.00N/AN/AN/AN/AN/A

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Datatec Limited stock logo
DTTLY
Datatec
$0.154.17%N/AN/AN/A
Allkem Limited stock logo
OROCF
Allkem
N/AN/AN/AN/AN/A
Oxford Biomedica plc stock logo
OXBDF
Oxford Biomedica
N/AN/AN/AN/AN/A
Pharma Mar, S.A. stock logo
PHMMF
Pharma Mar
N/AN/AN/AN/AN/A
SThree plc stock logo
STREF
SThree
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Datatec Limited stock logo
DTTLY
Datatec
0.08
1.05
0.91
Allkem Limited stock logo
OROCF
Allkem
0.08
2.52
2.23
Oxford Biomedica plc stock logo
OXBDF
Oxford Biomedica
N/AN/AN/A
Pharma Mar, S.A. stock logo
PHMMF
Pharma Mar
0.13
3.01
2.61
SThree plc stock logo
STREF
SThree
N/AN/AN/A

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Datatec Limited stock logo
DTTLY
Datatec
N/A
Allkem Limited stock logo
OROCF
Allkem
N/A
Oxford Biomedica plc stock logo
OXBDF
Oxford Biomedica
N/A
Pharma Mar, S.A. stock logo
PHMMF
Pharma Mar
N/A
SThree plc stock logo
STREF
SThree
N/A

Insider Ownership

CompanyInsider Ownership
Datatec Limited stock logo
DTTLY
Datatec
N/A
Allkem Limited stock logo
OROCF
Allkem
N/A
Oxford Biomedica plc stock logo
OXBDF
Oxford Biomedica
N/A
Pharma Mar, S.A. stock logo
PHMMF
Pharma Mar
1.88%
SThree plc stock logo
STREF
SThree
N/A

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Datatec Limited stock logo
DTTLY
Datatec
10,500114.76 millionN/ANot Optionable
Allkem Limited stock logo
OROCF
Allkem
1,350N/AN/ANot Optionable
Oxford Biomedica plc stock logo
OXBDF
Oxford Biomedica
89196.26 millionN/ANot Optionable
Pharma Mar, S.A. stock logo
PHMMF
Pharma Mar
509N/AN/ANot Optionable
SThree plc stock logo
STREF
SThree
2,894N/AN/ANot Optionable

OXBDF, OROCF, STREF, DTTLY, and PHMMF Headlines

SourceHeadline
Berenberg starts recruiter SThree at ‘buy’Berenberg starts recruiter SThree at ‘buy’
sharecast.com - February 6 at 7:27 AM
SThree: Change of RegistrarSThree: Change of Registrar
cbonds.com - January 24 at 9:56 PM
SThree Insider Ups Holding By 26% During YearSThree Insider Ups Holding By 26% During Year
uk.finance.yahoo.com - December 23 at 4:51 AM
SThree: Directorate ChangeSThree: Directorate Change
cbonds.com - December 9 at 8:45 AM
SThrees (LON:STEM) investors will be pleased with their notable 46% return over the last three yearsSThree's (LON:STEM) investors will be pleased with their notable 46% return over the last three years
finance.yahoo.com - October 12 at 7:33 AM
FINANCIALS: SThree’s Q3 trading update reveals ‘resilience’FINANCIALS: SThree’s Q3 trading update reveals ‘resilience’
recruiter.co.uk - September 21 at 9:38 AM
Calculating The Intrinsic Value Of SThree plc (LON:STEM)Calculating The Intrinsic Value Of SThree plc (LON:STEM)
finance.yahoo.com - August 11 at 2:08 AM
SThree posts fall in HY profit on higher operating costsSThree posts fall in HY profit on higher operating costs
uk.movies.yahoo.com - July 25 at 8:01 AM
SThree touts tech strategy despite interim profit drop on expensesSThree touts tech strategy despite interim profit drop on expenses
lse.co.uk - July 25 at 8:01 AM
SThree Sees FY 2023 in Line With Views After 1H Pretax Profit FellSThree Sees FY 2023 in Line With Views After 1H Pretax Profit Fell
marketwatch.com - July 25 at 8:01 AM
SThrees first-half profit falls on higher operating costsSThree's first-half profit falls on higher operating costs
msn.com - July 25 at 8:01 AM
Life sciences slowdown hits recruiter SThreeLife sciences slowdown hits recruiter SThree
thetimes.co.uk - June 20 at 8:45 PM
SThree: SBTi-verified net-zero target and 2022 Impact ReportSThree: SBTi-verified net-zero target and 2022 Impact Report
markets.businessinsider.com - April 12 at 4:08 AM
SThree (LON:STEM) Is Paying Out A Larger Dividend Than Last YearSThree (LON:STEM) Is Paying Out A Larger Dividend Than Last Year
finance.yahoo.com - April 5 at 8:16 AM
SThree ensures it offers multi-faith support in the workplaceSThree ensures it offers multi-faith support in the workplace
employeebenefits.co.uk - March 31 at 1:24 PM
SThree: BLR-Block listing Interim Review*SThree: BLR-Block listing Interim Review*
uk.finance.yahoo.com - February 23 at 6:15 PM
IR35 on the ground: Where SThree is seeing off-payroll compliance (with a little help from itself)IR35 on the ground: Where SThree is seeing off-payroll compliance (with a little help from itself)
contractoruk.com - February 7 at 7:00 AM
Recruiter SThree on hot streak before job market coolsRecruiter SThree on hot streak before job market cools
thetimes.co.uk - December 14 at 10:52 PM
SThree delivers record FY performanceSThree delivers 'record' FY performance
sharecast.com - December 14 at 7:50 AM
SThree Sees FY 2022 Double-Digit Net Fee Growth, Beating Management ViewsSThree Sees FY 2022 Double-Digit Net Fee Growth, Beating Management Views
marketwatch.com - December 14 at 2:50 AM
SThree: Notice of Second Investor BriefingSThree: Notice of Second Investor Briefing
markets.businessinsider.com - December 14 at 2:50 AM
SThree: FY 2022 Trading UpdateSThree: FY 2022 Trading Update
markets.businessinsider.com - December 14 at 2:50 AM
SThree: Block Listing of SharesSThree: Block Listing of Shares
uk.finance.yahoo.com - August 18 at 7:03 AM
SThree 1H 2022 Pretax Profit Rose on Higher Revenue; Well Positioned for 2HSThree 1H 2022 Pretax Profit Rose on Higher Revenue; Well Positioned for 2H
marketwatch.com - July 25 at 7:57 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Datatec logo

Datatec

OTCMKTS:DTTLY
Datatec Limited, together with its subsidiaries, provides information and communication technology (ICT) solutions and services worldwide. It operates in four segments: Westcon International, Logicalis International, Logicalis Latin America, and Corporate and Management Consulting. The company distributes cyber security, network infrastructure, unified collaboration products, data centre solutions, and channel services; and offers financing/leasing solutions for ICT customers. It offers solutions through a network of service providers, systems integrators, and specialty resellers under the Westcon and Comstor brands. The company also provides digital services; and strategic, trusted advisory, modeling, and market intelligence services to the telecoms, media, and technology industries. Datatec Limited was founded in 1986 and is headquartered in Sandown, South Africa.
Allkem logo

Allkem

OTCMKTS:OROCF
Allkem Limited engages in the production and sale of lithium and boron in Argentina. Its flagship project is the Olaroz Lithium Facility located in Jujuy province in northern Argentina. Allkem Limited was incorporated in 2005 and is headquartered in Brisbane, Australia.
Oxford Biomedica logo

Oxford Biomedica

OTCMKTS:OXBDF
Oxford Biomedica plc, a contract development and manufacturing organization, focuses on delivering therapies to patients worldwide. Its s LentiVector platform technology is an advanced lentiviral vector based gene delivery system which is designed to overcome the safety and delivery problems associated with earlier generations of vector systems. The company operates in two segments, Platform and Product. The Platform segment engages in bioprocessing and process development activities for third parties. The Product segment is involved in the research and development of new gene therapeutic product candidates. The company collaborates with pharmaceutical and biotechnology companies providing viral vector development and manufacturing services in lentivirus, adeno-associated virus, and adenoviral vectors. The company was formerly known as Pinco 838 Limited and changed its name to Oxford Biomedica plc in October 1996. Oxford Biomedica plc was incorporated in 1996 and is headquartered in Oxford, the United Kingdom.
Pharma Mar logo

Pharma Mar

OTCMKTS:PHMMF
Pharma Mar, S.A., a biopharmaceutical company, engages in the research, development, production, and commercialization of bio-active principles of marine origin for use in oncology in Spain, Italy, Germany, Ireland, France, rest of EU, the United States, and internationally. The company operates through Oncology and RNA interference segments. It develops and commercializes Yondelis for the treatment of soft tissue sarcoma and for ovarian cancer; Aplidin for treating R/R multiple myeloma; and Zepzelca for treating patients with small cell lung cancer. The company also develops PM14, which is in phase II clinical trials for the treatment of solid tumors, as well as in Phase I clinical trial for the treatment of soft tissue sarcoma and prostate cancer; PM534 that is Phase I clinical trial for treating solid tumors; Tivanisiran, which is in Phase III clinical trial for the treatment of dry eye disease; and SYL1801 that is in phase II clinical trial for treating macular degeneration. In addition, it engages in the development, production, and sale of products with therapeutic activity based on reducing or silencing gene expression. The company was incorporated in 1986 and is based in Madrid, Spain.
SThree logo

SThree

OTCMKTS:STREF
SThree plc provides specialist contract and permanent staffing services for technology, engineering, life sciences, banking and finance, and other sectors. It offers permanent, contract, project, retained, and executive search recruitment solutions, as well as support and mobility services. The company provides its services under the Computer Futures, Progressive, Huxley, Real Staffing Group, Global Enterprise Partners, JP Gray, Madison Black, Newington International, and Orgtel brands. It has operations in the United Kingdom, Germany, the United States, the Netherlands, Japan, Dubai, Belgium, France, Ireland, Luxembourg, Spain, Austria, Switzerland, Hong Kong, Malaysia, Singapore, and internationally. SThree plc was founded in 1986 and is headquartered in London, the United Kingdom.